Agnes G Oomen

Grouping nanomaterials to predict their potential to induce pulmonary inflammation.

Hedwig M Braakhuis, Agnes G Oomen, Flemming R Cassee, 2016, Toxicology and applied pharmacology.

A practical approach to determine dose metrics for nanomaterials

Jingwen Chen, Agnes G Oomen, Christiaan J E Delmaar, 2015, Environmental toxicology and chemistry.

Towards a nanospecific approach for risk assessment.

Adriele Prina-Mello, Maria João Silva, Agnes G Oomen, 2016, Regulatory toxicology and pharmacology : RTP.

Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study.

Agnes G Oomen, Flemming R Cassee, Jeffry D Schroeter, 2012, Toxicological sciences : an official journal of the Society of Toxicology.

Horizon scan of nanomedicinal products.

Agnes G Oomen, Margriet V D Z Park, Rob J Vandebriel, 2015, Nanomedicine.

Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats.

Srirang Manohar, Agnes G Oomen, Ton G van Leeuwen, 2011, Nanomedicine.

What do we (need to) know about the kinetic properties of nanoparticles in the body?

Agnes G Oomen, Flemming R Cassee, Wim H de Jong, 2007, Regulatory toxicology and pharmacology : RTP.

Comparison of five in vitro digestion models to study the bioaccessibility of soil contaminants.

Willy Verstraete, Agnes G Oomen, Christa Cornelis, 2002, Environmental science & technology.

Considerations on the EU definition of a nanomaterial: science to support policy making.

Dik van de Meent, Agnes G Oomen, Flemming R Cassee, 2013, Regulatory toxicology and pharmacology : RTP.